Palbociclib After CDK and Endocrine Therapy (PACE)
Clinical trial NCT03147287 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03147287
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-05
- Primary completion
- 2022-12-31
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.